REGN Stock Ownership Activity

REGENERON PHARMACEUTICALS 13F holders

1 value investing guru has made changes to the REGENERON PHARMACEUTICALS (REGN) position according to the gurus' latest SEC quarterly report(s). REGN has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds are buying REGN now?

According to the latest SEC filing(s) REGENERON PHARMACEUTICALS (REGN) has been bought by Ole Andreas Halvorsen - Viking Global Investors (new buy).

To see more about who is investing in REGENERON PHARMACEUTICALS (REGN), please go to the REGN ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2014 Q2 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
+181.75%
+1,911,656
+2.36%
3.65%
David M. Polen
Polen Capital Management
-4.82%
-10,573
-0.07%
1.29%
Current price: $744.50 163.57% AVG reported price*: $282.47
2014 Q1 (2 results)
Ole Andreas Halvorsen
Viking Global Investors
buy
+1,051,800
+1.32%
1.32%
David M. Polen
Polen Capital Management
+12,416.45%
+217,412
+1.41%
1.42%
Current price: $744.50 147.94% AVG reported price*: $300.28
2013 Q2 (1 result)
David M. Polen
Polen Capital Management
buy
+1,751
+0.01%
0.01%
Current price: $744.50 230.87% Reported price*: $225.01
5 of 54

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.